A	O
convergent	O
synthesis	O
of	O
novel	O
alkyne	O
-	O
azide	O
cycloaddition	O
congeners	O
of	O
betulinic	B:C0053530
acid	I:C0053530
as	O
potent	O
cytotoxic	O
agent	I:C0304497
.	O

A	O
convergent	O
synthesis	O
of	O
novel	O
alkyne	O
-	O
azide	O
cycloaddition	O
congeners	O
of	O
betulinic	O
acid	I:C0053530
as	O
potent	O
cytotoxic	B:C0304497
agent	I:C0304497
.	O

In	O
an	O
endeavour	O
to	O
develop	O
potent	O
anti-tumor	B:C0003392
agents	I:C0003392
from	O
betulinic	O
acid	I:C0053530
(	O
betulinic	O
acid	I:C0053530
)	O
,	O
a	O
series	O
of	O
C	O
-	O
28	O
derived	O
1,2,3	O
-	I:C0040880
triazolyl	I:C0040880
derivatives	I:C0040880
were	O
designed	O
and	O
synthesized	O
by	O
employing	O
Cu(	O
I	I:C0009968
)	I:C0009968
catalyzed	O
Huisgen	O
1,3	O
-	O
dipolar	O
cycloaddition	O
reaction	O
.	O

In	O
an	O
endeavour	O
to	O
develop	O
potent	O
anti-tumor	O
agents	I:C0003392
from	O
betulinic	B:C0053530
acid	I:C0053530
(	O
betulinic	O
acid	I:C0053530
)	O
,	O
a	O
series	O
of	O
C	O
-	O
28	O
derived	O
1,2,3	O
-	I:C0040880
triazolyl	I:C0040880
derivatives	I:C0040880
were	O
designed	O
and	O
synthesized	O
by	O
employing	O
Cu(	O
I	I:C0009968
)	I:C0009968
catalyzed	O
Huisgen	O
1,3	O
-	O
dipolar	O
cycloaddition	O
reaction	O
.	O

In	O
an	O
endeavour	O
to	O
develop	O
potent	O
anti-tumor	O
agents	I:C0003392
from	O
betulinic	O
acid	I:C0053530
(	O
betulinic	B:C0053530
acid	I:C0053530
)	O
,	O
a	O
series	O
of	O
C	O
-	O
28	O
derived	O
1,2,3	O
-	I:C0040880
triazolyl	I:C0040880
derivatives	I:C0040880
were	O
designed	O
and	O
synthesized	O
by	O
employing	O
Cu(	O
I	I:C0009968
)	I:C0009968
catalyzed	O
Huisgen	O
1,3	O
-	O
dipolar	O
cycloaddition	O
reaction	O
.	O

In	O
an	O
endeavour	O
to	O
develop	O
potent	O
anti-tumor	O
agents	I:C0003392
from	O
betulinic	O
acid	I:C0053530
(	O
betulinic	O
acid	I:C0053530
)	O
,	O
a	O
series	O
of	O
C	O
-	O
28	O
derived	O
1,2,3	B:C0040880
-	I:C0040880
triazolyl	I:C0040880
derivatives	I:C0040880
were	O
designed	O
and	O
synthesized	O
by	O
employing	O
Cu(	O
I	I:C0009968
)	I:C0009968
catalyzed	O
Huisgen	O
1,3	O
-	O
dipolar	O
cycloaddition	O
reaction	O
.	O

In	O
an	O
endeavour	O
to	O
develop	O
potent	O
anti-tumor	O
agents	I:C0003392
from	O
betulinic	O
acid	I:C0053530
(	O
betulinic	O
acid	I:C0053530
)	O
,	O
a	O
series	O
of	O
C	O
-	O
28	O
derived	O
1,2,3	O
-	I:C0040880
triazolyl	I:C0040880
derivatives	I:C0040880
were	O
designed	O
and	O
synthesized	O
by	O
employing	O
Cu(	B:C0009968
I	I:C0009968
)	I:C0009968
catalyzed	O
Huisgen	O
1,3	O
-	O
dipolar	O
cycloaddition	O
reaction	O
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	B:C0243095
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	B:C2986858
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	B:C0086418
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	B:C0085983
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	B:C4277577
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	B:C1258005
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	B:C0085983
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	B:C0085983
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	O
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

All	O
the	O
derivatives	O
were	O
evaluated	O
for	O
cytotoxic	O
activity	I:C0243095
by	O
MTT	O
assay	I:C2986858
against	O
five	O
different	O
human	O
cancer	O
cell	I:C0085983
lines	I:C0085983
:	O
lung	O
(	I:C4277577
A549	I:C4277577
)	I:C4277577
,	O
colon	O
(	I:C1258005
HCT116	I:C1258005
)	I:C1258005
,	O
prostate	O
(	I:C0085983
PC3	I:C0085983
)	O
,	O
pancreatic	O
(	I:C0085983
MIA	I:C0085983
PaCa	I:C0085983
-	I:C0085983
2	I:C0085983
)	I:C0085983
and	O
breast	B:C1512505
(	I:C1512505
T47D	I:C1512505
)	I:C1512505
.	O

The	O
data	O
revealed	O
that	O
compounds	B:C1254351
11c	I:C1254351
,	O
11d	O
,	O
11g	O
,	O
11h	O
and	O
13a	O
possess	O
most	O
promising	O
cytotoxic	O
potential	O
.	O

The	O
data	O
revealed	O
that	O
compounds	O
11c	I:C1254351
,	O
11d	B:C1254351
,	O
11g	O
,	O
11h	O
and	O
13a	O
possess	O
most	O
promising	O
cytotoxic	O
potential	O
.	O

The	O
data	O
revealed	O
that	O
compounds	O
11c	I:C1254351
,	O
11d	O
,	O
11g	B:C1254351
,	O
11h	O
and	O
13a	O
possess	O
most	O
promising	O
cytotoxic	O
potential	O
.	O

The	O
data	O
revealed	O
that	O
compounds	O
11c	I:C1254351
,	O
11d	O
,	O
11g	O
,	O
11h	B:C1254351
and	O
13a	O
possess	O
most	O
promising	O
cytotoxic	O
potential	O
.	O

The	O
data	O
revealed	O
that	O
compounds	O
11c	I:C1254351
,	O
11d	O
,	O
11g	O
,	O
11h	O
and	O
13a	B:C1254351
possess	O
most	O
promising	O
cytotoxic	O
potential	O
.	O

The	O
data	O
revealed	O
that	O
compounds	O
11c	I:C1254351
,	O
11d	O
,	O
11g	O
,	O
11h	O
and	O
13a	O
possess	O
most	O
promising	O
cytotoxic	B:C0596402
potential	O
.	O

The	O
compound	B:C1254351
11h	I:C1254351
was	O
one	O
of	O
the	O
most	O
active	O
compounds	I:C1254351
,	O
with	O
IC50	O
values	O
in	O
the	O
range	O
of	O
4	O
-	O
6	O
µ	O
M	O
against	O
all	O
the	O
five	O
cancer	O
cell	I:C0085983
lines	I:C0085983
.	O

The	O
compound	O
11h	I:C1254351
was	O
one	O
of	O
the	O
most	O
active	B:C1254351
compounds	I:C1254351
,	O
with	O
IC50	O
values	O
in	O
the	O
range	O
of	O
4	O
-	O
6	O
µ	O
M	O
against	O
all	O
the	O
five	O
cancer	O
cell	I:C0085983
lines	I:C0085983
.	O

The	O
compound	O
11h	I:C1254351
was	O
one	O
of	O
the	O
most	O
active	O
compounds	I:C1254351
,	O
with	O
IC50	O
values	O
in	O
the	O
range	O
of	O
4	O
-	O
6	O
µ	O
M	O
against	O
all	O
the	O
five	O
cancer	B:C0085983
cell	I:C0085983
lines	I:C0085983
.	O

The	O
results	O
of	O
this	O
study	B:C2603343
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	B:C1254351
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	B:C1254351
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	B:C1254351
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	B:C1254351
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	B:C1254351
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	B:C0040880
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	B:C0450429
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	B:C0243095
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	B:C0450429
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	B:C1254351
leads	I:C1254351
from	O
betulinic	O
acid	I:C0053530
.	O

The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
derivatives	O
with	O
free	O
-	O
OH	O
(	O
11	O
c	I:C1254351
,	O
11d	O
and	O
11g	O
)	O
and	O
free	O
-	O
COOH	O
(	O
11h	O
and	O
13a	O
)	O
substitutions	O
in	O
the	O
triazole	O
moiety	I:C0040880
introduced	O
at	O
the	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
significantly	O
improved	O
the	O
anti-tumor	O
activity	I:C0243095
and	O
may	O
be	O
the	O
favourable	O
position	I:C0450429
to	O
synthesize	O
potent	O
anticancer	O
leads	I:C1254351
from	O
betulinic	B:C0053530
acid	I:C0053530
.	O

Introduction	O
of	O
a	O
non	O
polar	O
alkyl	O
groups	O
at	O
C	B:C0450429
-	I:C0450429
28	I:C0450429
position	I:C0450429
(	O
10	O
,	O
12	O
and	O
14	O
)	O
resulted	O
in	O
the	O
significant	O
loss	O
of	I:C0243095
the	I:C0243095
activity	I:C0243095
.	O

Introduction	O
of	O
a	O
non	O
polar	O
alkyl	O
groups	O
at	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
(	O
10	B:C1254351
,	O
12	O
and	O
14	O
)	O
resulted	O
in	O
the	O
significant	O
loss	O
of	I:C0243095
the	I:C0243095
activity	I:C0243095
.	O

Introduction	O
of	O
a	O
non	O
polar	O
alkyl	O
groups	O
at	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
(	O
10	O
,	O
12	B:C1254351
and	O
14	O
)	O
resulted	O
in	O
the	O
significant	O
loss	O
of	I:C0243095
the	I:C0243095
activity	I:C0243095
.	O

Introduction	O
of	O
a	O
non	O
polar	O
alkyl	O
groups	O
at	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
(	O
10	O
,	O
12	O
and	O
14	B:C1254351
)	O
resulted	O
in	O
the	O
significant	O
loss	O
of	I:C0243095
the	I:C0243095
activity	I:C0243095
.	O

Introduction	O
of	O
a	O
non	O
polar	O
alkyl	O
groups	O
at	O
C	O
-	I:C0450429
28	I:C0450429
position	I:C0450429
(	O
10	O
,	O
12	O
and	O
14	O
)	O
resulted	O
in	O
the	O
significant	O
loss	B:C0243095
of	I:C0243095
the	I:C0243095
activity	I:C0243095
.	O

Further	O
,	O
DAPI	B:C0057142
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	B:C0487602
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	B:C3894443
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	B:C0043240
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	B:C0681814
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	B:C1254351
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	B:C0162638
in	O
HCT	O
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

Further	O
,	O
DAPI	O
staining	O
,	O
ROS	O
generation	I:C3894443
and	O
wound	O
healing	I:C0043240
experiments	O
revealed	O
that	O
compound	O
11h	I:C1254351
induces	O
apoptosis	O
in	O
HCT	B:C1258005
-	I:C1258005
116	I:C1258005
cells	I:C1258005
.	O

